Living PlatformLtd Valuation
Is 7091 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 7091 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 7091's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 7091's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 7091?
Other financial metrics that can be useful for relative valuation.
What is 7091's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | JP¥4.48b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | -72.8x |
PEG Ratio | 1x |
Price to Earnings Ratio vs Peers
How does 7091's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 29.9x | ||
6034 MRT | 8.8x | n/a | JP¥4.5b |
8769 Advantage Risk Management | 13.5x | n/a | JP¥6.2b |
9214 Recovery InternationalLtd | 21.9x | n/a | JP¥2.4b |
6059 UCHIYAMA HOLDINGSLtd | 75.3x | n/a | JP¥6.6b |
7091 Living PlatformLtd | 34.1x | 35.8% | JP¥4.5b |
Price-To-Earnings vs Peers: 7091 is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the peer average (29.9x).
Price to Earnings Ratio vs Industry
How does 7091's PE Ratio compare vs other companies in the JP Healthcare Industry?
Price-To-Earnings vs Industry: 7091 is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the JP Healthcare industry average (15.2x).
Price to Earnings Ratio vs Fair Ratio
What is 7091's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 34.1x |
Fair PE Ratio | 27.8x |
Price-To-Earnings vs Fair Ratio: 7091 is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the estimated Fair Price-To-Earnings Ratio (27.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.